Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06231017
Status:
RECRUITING
Last Update Posted:
2024-01-30
First Post:
2024-01-21
Brief Title:
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RASBRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01-19
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-21
First Submit QC Date:
January 21 2024
Study First Post Date:
2024-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-21
Last Update Post Date:
2024-01-30
Last Update Post Date Type:
ACTUAL